Sentences with phrase «bluebird bio»

Between 2013 and 2018, Asiya has worked at bluebird bio in Cambridge MA in Business Development, Alliance Management and Research Strategy roles.

In the biotechnology sector, Canter Fitzgerald analyst Elemer Piros increased his price target for bluebird bio Inc (NASDAQ: BLUE) from $ 39 to $ 58, but he maintains an Underweight rating.

Sean currently conducts cancer research at Bluebird Bio in Cambridge.

Celgene bet early (and big) on companies like Agios Pharmaceuticals and Bluebird Bio before they went public, Timmerman wrote.

Celgene and bluebird bio report a stunning success in multiple myeloma, Juno Therapeutics takes it on the chin despite positive data, and Spark Therapeutics suffers in its showdown with BioMarin in hemophilia.

But gene therapy companies - which also include Bluebird Bio, BioMarin, Sangamo and GenSight - may need new business models.

-- The NEJM published updates from two early - stage Bluebird Bio (NASDAQ: BLUE) studies of a gene therapy for the rare disease beta - thalassemia, which requires patients to... Next Page»

Before moving to the US and joining bluebird bio, Asiya worked as analyst intern at Forbion, participating in the deal - flow team.

Prior to joining Lysogene, he was the Director of Regulatory Affairs at bluebird bio leading efforts on the treatment of the rare disease CCALD through LVV gene therapy where he initiated and led the RA CMC group across all programs including CNS, hematology and oncology.

Kite is one of the leading players in the emerging field of CAR T, and is competing with rivals Novartis AG, Juno Therapeutics Inc and Bluebird Bio Inc in a race to get the first approved therapy.

One of the top contributors to the gain was bluebird bio, which is also working on CAR - T cell therapy.

Kite Pharma, Juno Therapeutics, and Bluebird Bio are among a growing group of biotech companies working with CAR - T.

bluebird bio (BLUE)- The company's BCMA CAR - T drug candidate bb2121 remains attractive despite overblown fears on durability (peak sales of $ 2 billion or more), LentiGlobin has a good shot at success in TDT (Transfusion - Dependent ß - Thalassemia) and SCD (Severe Sickle Cell Disease), and they have a strong cash position.

Bluebird Bio (BLUE)- The company's data in beta - thalassemia was highlighted in the Wall Street Journal.

bluebird bio Inc (NASDAQ: BLUE) reported compelling data over the weekend at the American Society of Hematology that some experts described as «unheard of.»

Bluebird Bio (NASDAQ: BLUE) and Novartis (NYSE: NVS) have the most advanced CAR - T programs for myeloma, with Bluebird and partner Celgene (NASDAQ: CELG) planning a pivotal study this year.

Celgene and Bluebird Bio have revealed updated data from an ongoing Phase I clinical trial of bb2121 at the ASH Annual Meeting in Atlanta.

The industry has seen investors of all types maintaining their interest in cell and gene therapy, with a number of new deals made: e.g., Bluebird bio and Medigene signed a strategic R&D collaboration and licensing agreement, and...

9 of the 10 trades triggered this week, and 6 remained open at the close Friday, bluebird bio, Dunkin' Brands, Ingredion, Tractor Supply, Biogen and Diageo.